THY1 and hepatocellular carcinoma: These data indicate that siRNA inhibition of MAP3K8 also suppressed the stemness of CD90+ CSCs even in the absence of miR-589-5p overexpression, and miR-589-5p likely functions through MAP3K8 to suppress CSC stemness and HCC progression.